A carregar...
Functional characterization of CYP2D6 enhancer polymorphisms
CYP2D6 metabolizes nearly 25% of clinically used drugs. Genetic polymorphisms cause large inter-individual variability in CYP2D6 enzyme activity and are currently used as biomarker to predict CYP2D6 metabolizer phenotype. Previously, we had identified a region 115 kb downstream of CYP2D6 as enhancer...
Na minha lista:
| Publicado no: | Hum Mol Genet |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381757/ https://ncbi.nlm.nih.gov/pubmed/25381333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddu566 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|